Group One Trading, L.P. Fibrogen Inc Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.89 - $2.36 $66,318 - $175,855
74,515 Added 91.52%
155,938 $138,000
Q1 2024

May 10, 2024
BUY
$0.73 - $2.73 $59,438 - $222,284
81,423 New
81,423 $191,000
Q1 2023

May 12, 2023
BUY
$15.95 - $25.18 $425,912 - $672,381
26,703 Added 38.22%
96,572 $1.8 Million
Q4 2022

Feb 09, 2023
BUY
$13.27 - $17.73 $303,285 - $405,219
22,855 Added 48.61%
69,869 $1.12 Million
Q3 2022

Nov 09, 2022
BUY
$11.4 - $14.6 $193,412 - $247,703
16,966 Added 56.46%
47,014 $612,000
Q2 2022

Aug 11, 2022
SELL
$7.94 - $12.96 $322,641 - $526,629
-40,635 Reduced 57.49%
30,048 $317,000
Q1 2022

May 12, 2022
SELL
$12.02 - $16.79 $128,013 - $178,813
-10,650 Reduced 13.09%
70,683 $850,000
Q4 2021

Feb 11, 2022
SELL
$9.93 - $15.39 $445,012 - $689,702
-44,815 Reduced 35.53%
81,333 $1.15 Million
Q3 2021

Nov 12, 2021
SELL
$10.18 - $26.64 $191,231 - $500,432
-18,785 Reduced 12.96%
126,148 $1.29 Million
Q2 2021

Aug 10, 2021
BUY
$18.57 - $35.68 $1.31 Million - $2.52 Million
70,600 Added 94.98%
144,933 $3.86 Million
Q1 2021

May 12, 2021
SELL
$31.0 - $55.72 $17,856 - $32,094
-576 Reduced 0.77%
74,333 $2.58 Million
Q4 2020

Feb 10, 2021
BUY
$37.09 - $48.97 $2.2 Million - $2.9 Million
59,269 Added 378.96%
74,909 $2.78 Million
Q3 2020

Nov 12, 2020
SELL
$40.47 - $45.5 $1.14 Million - $1.28 Million
-28,060 Reduced 64.21%
15,640 $643,000
Q2 2020

Aug 13, 2020
BUY
$32.57 - $42.83 $79,796 - $104,933
2,450 Added 5.94%
43,700 $1.77 Million
Q1 2020

May 13, 2020
SELL
$23.3 - $45.96 $651,654 - $1.29 Million
-27,968 Reduced 40.41%
41,250 $1.43 Million
Q4 2019

Feb 10, 2020
BUY
$34.58 - $48.06 $720,093 - $1 Million
20,824 Added 43.03%
69,218 $2.97 Million
Q3 2019

Nov 12, 2019
SELL
$36.98 - $48.45 $1.7 Million - $2.23 Million
-46,103 Reduced 48.79%
48,394 $1.79 Million
Q2 2019

Aug 09, 2019
SELL
$35.13 - $55.53 $478,857 - $756,929
-13,631 Reduced 12.61%
94,497 $4.27 Million
Q1 2019

May 13, 2019
BUY
$42.83 - $59.91 $2.11 Million - $2.96 Million
49,371 Added 84.03%
108,128 $5.88 Million
Q4 2018

Feb 06, 2019
BUY
$37.97 - $60.16 $1.53 Million - $2.42 Million
40,227 Added 217.09%
58,757 $2.72 Million
Q3 2018

Nov 08, 2018
BUY
$56.3 - $67.25 $1.04 Million - $1.25 Million
18,530 New
18,530 $1.13 Million
Q2 2018

Aug 14, 2018
SELL
$44.9 - $64.95 $450,975 - $652,357
-10,044 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$45.35 - $61.65 $318,855 - $433,461
7,031 Added 233.36%
10,044 $464,000
Q4 2017

Feb 09, 2018
SELL
$41.95 - $60.1 $752,079 - $1.08 Million
-17,928 Reduced 85.61%
3,013 $143,000
Q3 2017

Nov 15, 2017
SELL
$33.4 - $53.9 $475,816 - $767,859
-14,246 Reduced 40.49%
20,941 $1.13 Million
Q2 2017

Aug 14, 2017
BUY
N/A
35,187
35,187 $1.14 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email